AstraZeneca CEO: China already a global innovation hub
Multinational pharmaceutical company AstraZeneca is bullish about China’s role as a global innovation powerhouse, underpinned by the country’s sound prospects as well as its growing innovation capability in new and emerging sectors, its top executive said. Pascal Soriot, global CEO of AstraZeneca, said in an exclusive interview with China Daily that the company is investing…